Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza A(H5N1)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01195038
What this trial is testing

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Who this might be right for
Influenza
UMN Pharma Inc. 87
Early research (Phase 1)Study completedNCT00694213
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Who this might be right for
Influenza
Vical 47
Early research (Phase 1)Study completedNCT00532792
What this trial is testing

A/H5N1 Dose Ranging Study With Adjuvant Patch

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 501
Testing effectiveness (Phase 2)Study completedNCT02691130
What this trial is testing

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

Who this might be right for
InfluenzaHealthy
BiondVax Pharmaceuticals ltd. 224
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Testing effectiveness (Phase 2)Study completedNCT00561184
What this trial is testing

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Who this might be right for
Avian Influenza
Novartis Vaccines 47
Early research (Phase 1)Study completedNCT01403155
What this trial is testing

A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

Who this might be right for
Healthy
Inovio Pharmaceuticals 22
Early research (Phase 1)Study completedNCT00853255
What this trial is testing

Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00519389
What this trial is testing

Safety, Reactogenicity and Immunogenicity of an H5N1 VLP

Who this might be right for
Pandemic Influenza
Novavax 230
Testing effectiveness (Phase 2)Study completedNCT00545701
What this trial is testing

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT00488046
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)Study completedNCT02719743
What this trial is testing

A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 185
Large-scale testing (Phase 3)Active Not RecruitingNCT07496450
What this trial is testing

MRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 4,050
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Testing effectiveness (Phase 2)Study completedNCT00680069
What this trial is testing

H5N1 (Clade 2) Vaccination of Adults and Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 517
Early research (Phase 1)Study completedNCT03196661
What this trial is testing

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

Who this might be right for
Influenza A
Hualan Biological Bacterin Co. Ltd. 588
Large-scale testing (Phase 3)Study completedNCT01911754
What this trial is testing

Japanese Pediatric H5N1 Vaccine Study

Who this might be right for
Influenza
Alachua Government Services, Inc. 60
Early research (Phase 1)Study completedNCT00912496
What this trial is testing

Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 637
Testing effectiveness (Phase 2)Study completedNCT03497845
What this trial is testing

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza A Virus, H5N1 Subtype
Biomedical Advanced Research and Development Authority 720
Testing effectiveness (Phase 2)Study completedNCT02213354
What this trial is testing

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

Who this might be right for
Avian Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 479
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation